D07001-softgel capsules + Xeloda (or TS-1) Clinical Trials

1 actively recruiting trial

Also known as: Treatment group

Pipeline

Phase 2/3: 1

Top Sponsors

InnoPharmax Inc.1

Indications

Biliary Tract Cancer1
Cancer1

Other1 trial

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.